Sarah A.
- Country
- Germany
- Department
- Onkologie, Hämatologie, Rheumatologie und klinische Immunologie
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematopoietic cell transplantation complications
- Venetoclax in combination with the BTK inhibitor Ibrutinib and Rituximab or conventional chemotherapy (Bendamustine) and Ibrutinib and Rituximab in patients with treatment naive Mantle Cell Lymphoma not eligible for high dose therapy
Data & Insights
Has run more than one trial at 58 of 225 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating chronic myeloid leukemia and other hematologic malignancies. Their research extends to innovative therapeutic approaches for blood cancers, particularly focusing on novel treatment modalities.
- Chronic Myeloid Leukemia Management
- Blood Cancer Therapeutics
- Hematologic Malignancy Treatment
Transplant Medicine
The investigator focuses on allogeneic hematopoietic cell transplantation and its complications. Their work includes exploring microbiome-based interventions to improve transplant outcomes in patients with blood disorders.
- Transplant Complications Prevention
- Microbiome Therapeutics
- Post-Transplant Care
Pediatric Oncology
The investigator has significant expertise in treating Ewing sarcoma, focusing on optimizing treatment protocols. Their work encompasses both standard-risk and high-risk disease management strategies.
- Sarcoma Treatment Protocols
- Maintenance Therapy Approaches
- Radiation Therapy Optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.